NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIEHS E-129-2004-0-PCT-02 Thermostable UvrA, UvrB, And UvrC Polypeptides and Methods of Use PCT PCT PCT/US02/25474 Abandoned
NEI E-185-1992-2-US-04 RETINAL PIGMENTED EPITHELUIM DERIVED NEUROTROPHIC FACTOR US DIV 10/216,373 7511009 Expired PDF
NIAID E-095-2000-0-US-03 IDENTIFICATION OF A NOVEL DOMAIN IN THE TUMOR NECROSIS FACTOR RECEPTOR FAMILY THAT MEDIATES PRE-LIGAND RECEPTOR ASSEMBLY AND FUNCTION. US National Stage 10/203,495 7148061 Expired PDF
NCI E-009-2000-0-US-21 Anti-EGFRvIII scFvs with Improved Cytotoxicity and Yield, Immunotoxins Based Thereon, and Methods of Use Thereof US CON 10/203,675 7129332 Abandoned PDF
CC E-229-1999-0-US-04 Vessel Delineation in Magnetic Resonance Angiographic Images US National Stage 10/203,662 7003144 Abandoned PDF
NHLBI E-108-2001-0-PCT-02 Side-exit Catheter Fand Method for Its Use PCT PCT PCT/US02/25494 Abandoned
NHGRI E-002-1998-0-US-03 TUMOR TISSUE MICROARRAYS FOR RAPID MOLECULAR PROFILING US DIV 10/215,762 Abandoned
NIDCR E-268-2002-0-US-01 Creation of Stable Recombinant Protective Antigen (RPA) Molecule by Deletions of the Chymotryspin-Sensitive Loop and the Furin -Cleavage Loop US 60/402,285 Abandoned
NIAID E-355-2001-1-US-01 VAC-BAC Shuttle Vector System US 60/402,824 Abandoned
NEI E-345-2001-0-US-01 TRANSKETOLASE AS A THERAPEUTIC AND DIAGNOSTIC TARGET US 60/402,365 Abandoned
NCI E-009-2000-0-NZ-13 Anti-EGFRvIII SCFVS with Improved Cytotoxicity and Yield, Immunotoxins Based Thereon, and Methods of Use Thereof NZ National Stage 2052-06-22 Abandoned
NCI E-009-2000-0-CN-15 Anti-EGFRvIII scFvs with Improved Cytotoxicity and Yield, Immunotoxins Based Thereon, and Methods of Use Thereof CN National Stage 01807175.9 Abandoned
NICHD E-280-2002-0-US-01 Measurement Systems and Methods US 60/401,935 Abandoned
NCI E-088-2001-0-PCT-02 Diacylglycerol Mimetics And Methods of Using The Same as Protein Kinase C Alpha Activators And Apoptosis Inducers PCT PCT PCT/US02/25088 Abandoned
NCI E-277-2002-0-US-01 Structure of famoxadone in complex with cytochrome bc1 complex US 60/401,039 Abandoned
NCI E-025-1999-0-US-03 Interleukin-2 Receptor Associated Polypeptides US National Stage 10/089,009 Abandoned
NCI E-254-1999-0-US-03 New Tumor Suppressor Gene, p47ING3 US National Stage 10/203,532 7335749 Abandoned PDF
NIAID E-281-2001-0-PCT-02 Oral Treatment of Hemophilia PCT PCT PCT/US2002/024544 Expired
NINDS E-296-2000-0-US-02 Intercellular Delivery of a Herpes Simplex Virus VP22 Fusion Protein from Cells Infected with Lentriviral Vectors US ORD 10/212,634 Abandoned
NIAID E-281-2001-0-EP-04 Oral Treatment of Hemophilia EP National Stage 02756904.5 Abandoned
NCI E-306-2000-0-US-01 CROSS-LINKED NITRIC OXIDE-RELEASING POLYAMINE COATED SUBSTRATES, COMPOSITION COMPRISING SAME AND METHODS OF MAKING SAME. US 60/400,817 Abandoned
NCI E-059-2003-0-US-01 Use Of Layered Expression Scanning (LES) For Multiwell Plates US 60/400,874 Abandoned
NCI E-230-1997-0-AU-04 Human Papilloma Virus Inhibition By Anti-Sense Oligonucleotides AU DIV 2002300401 Abandoned
NCI E-052-1995-1-AU-08 METHOD FOR INCREASING THE ANTIGEN PRESENTING ABILITY OF LEUKEMIA CELLS AU National Stage 2002300335 Abandoned
NCI E-230-1997-0-AU-10 Human Papilloma Virus Inhibition By Anti-Sense Oligonucleotides AU DIV 2002300399 Abandoned
NIA E-049-2001-0-CA-05 GLP-1 EXENDIN-4 PEPTIDE ANALOGS AND USES THEREOF CA National Stage 2455963 Expired
NIA E-049-2001-0-DE-26 GLP-1, EXENDIN-4 PEPTIDE ANALOGS AND USES THEREOF DE EP 10177860.3 Expired
NIA E-049-2001-0-FR-27 GLP-1, EXENDIN-4 PEPTIDE ANALOGS AND USES THEREOF FR EP 10177860.3 Expired
NIA E-049-2001-0-GB-28 GLP-1, EXENDIN-4 PEPTIDE ANALOGS AND USES THEREOF GB EP 10177860.3 Expired
NIA E-049-2001-0-EP-16 GLP-1, EXENDIN-4 PEPTIDE ANALOGS AND USES THEREOF EP DIV 10177860.3 Expired
NCI E-081-2001-2-JP-08 INHIBITOR OF DNA METHYLATION JP DIV 2010-144618 Abandoned
NCI E-081-2001-2-GB-11 INHIBITOR OF DNA METHYLATION GB EP 02756825.2 Abandoned
NCI E-081-2001-2-FR-10 INHIBITOR OF DNA METHYLATION FR EP 02756825.2 Abandoned
NCI E-081-2001-2-DE-09 INHIBITOR OF DNA METHYLATION DE EP 02756825.2 Abandoned
NCI E-081-2001-2-EP-02 INHIBITOR OF DNA METHYLATION EP National Stage 02756825.2 Abandoned
NCI E-081-2001-2-CA-04 INHIBITOR OF DNA METHYLATION CA National Stage 2454147 Abandoned
NIA E-049-2001-0-EP-09 GLP-1, EXENDIN-4, PEPTIDE ANALOGS AND USES THEREOF EP DIV 08162544.4 Expired
NIA E-049-2001-0-EP-06 GLP-1, EXENDIN-4, PEPTIDE ANALOGS AND USES THEREOF EP National Stage 02748271.0 Expired
NIA E-049-2001-0-AU-04 GLP-1 Exendin-4 Peptide Analogs and Uses Thereof AU National Stage 2002317599 Expired
NCI E-081-2001-2-AU-03 INHIBITOR OF DNA METHYLATION AU National Stage 2002322805 Abandoned
NIDCR E-258-1998-0-US-03 Hybrid Adeno-Retroviral Vector for the Transfection of Cells US National Stage 10/182,644 7052904 Abandoned PDF
NIDDK E-104-1997-0-US-03 USE OF PENTOSAN POLYSULFATE TO TREAT CERTAIN CONDITIONS OF THE PROSTATE US CON 10/209,331 6828309 Abandoned PDF
NHGRI E-284-2001-1-PCT-01 Specific Inhibition of Gene Expression By Small Double Strands RNAS PCT PCT COMB PCT/US02/24226 Expired
NIA E-049-2001-0-PCT-02 GLP-1, Exendin-4, Peptide Analogs and Uses Thereof PCT PCT PCT/US2002/024141 Expired
NIDDK E-301-2001-0-PCT-02 Method of Using Metformin to Treat Hyperglycemic Conditions PCT PCT PCT/US2002/024225 Expired
NCI E-081-2001-2-PCT-01 INHIBITOR OF DNA METHYLATION PCT PCT COMB PCT/US02/24223 Expired
NIA E-049-2001-0-EP-25 GLP-1, EXENDIN-4 PEPTIDE ANALOGS AND USES THEREOF EP DIV 10177860.3 Abandoned
NCI E-081-2001-2-JP-05 INHIBITOR OF DNA METHYLATION JP National Stage 2003-517229 Abandoned
NIA E-049-2001-0-JP-08 GLP-1 Exendin-4 Peptide Analogs and Uses Thereof JP National Stage 2003-517083 Expired
NIA E-049-2001-0-IN-07 GLP-1 Exendin-4 Peptide Analogs and Uses Thereof IN National Stage 0488/DELNP/2004 Expired